Psychometric Properties of Generic Preference-Weighted Measures for Children and Adolescents: A Systematic Review
- PMID: 36404365
- DOI: 10.1007/s40273-022-01205-y
Psychometric Properties of Generic Preference-Weighted Measures for Children and Adolescents: A Systematic Review
Abstract
Introduction: Preference-weighted measures (PWMs)-also referred to as preference-based measures in the literature-of health status/health-related quality of life plays an essential role in estimating quality-adjusted life-years (QALY) for use in economic evaluations of healthcare products and interventions. However, as PWMs are first and foremost intended to accurately reflect respondent health status, they should ideally demonstrate good psychometric properties for the population in question. This study aimed to systematically review published evidence on the measurement properties of commonly used PWMs for children and adolescents.
Methods: Three electronic databases (PubMed, Medline, and PsycINFO) were searched for articles assessing the psychometric properties (content validity, construct validity-including convergent validity and known-group validity, test-retest reliability, and responsiveness) of the PWMs of interest (AQoL-6D, CHU9D, HUI2, HUI3, and EQ-5D-Y). The COsensus-based Standards for the selection of health Measurement INstruments methodology (COSMIN) guidelines were used to assess (a) the methodological quality of the studies included and (b) the psychometric performance of the instruments covered. Data were analysed overall as well as by population (country and disease group) and perspective (self-report or proxy-report). The study protocol was registered in the International Prospective Register of Systematic Reviews (PROSPERO) database (CRD42021277296).
Results: In total, 53 articles were included in this systematic review. Health Utilities Index (HUI) was tested only in patient populations, CHU9D was most frequently tested in general population samples, while EQ-5D-Y was tested in both populations. Overall, there was high-quality evidence supporting sufficient construct validity for all instruments except AQoL-6D. Evidence supporting test-retest and responsiveness was scarce. There was high-quality evidence supporting sufficient responsiveness of HUI2 and HUI3, and inconsistent test-retest reliability of CHU9D and EQ-5D-Y. Evidence for content validity was minimal and therefore not extracted and synthesized for any PWMs.
Conclusion: This review provides updated evidence on the measurement properties of existing generic PWMs for children and adolescents. High-quality evidence for all relevant psychometric properties and across a range of populations was not available for any of the instruments included, indicating that further work is needed in this direction. This study has identified some of the most noticeable evidence gaps for each of the individual measures. Users can use this information to guide their decision on the choice of PWM to administer.
© 2022. The Author(s), under exclusive licence to Springer Nature Switzerland AG.
Similar articles
-
Comparing the Psychometric Performance of Generic Paediatric Health-Related Quality of Life Instruments in Children and Adolescents with ADHD, Anxiety and/or Depression.Pharmacoeconomics. 2024 Jun;42(Suppl 1):57-77. doi: 10.1007/s40273-024-01354-2. Epub 2024 Feb 8. Pharmacoeconomics. 2024. PMID: 38329689 Free PMC article.
-
Systematic Review of the Psychometric Performance of Generic Childhood Multi-attribute Utility Instruments.Appl Health Econ Health Policy. 2023 Jul;21(4):559-584. doi: 10.1007/s40258-023-00806-8. Epub 2023 May 3. Appl Health Econ Health Policy. 2023. PMID: 37133712 Free PMC article.
-
Comparative Psychometric Performance of Common Generic Paediatric Health-Related Quality of Life Instrument Descriptive Systems: Results from the Australian Paediatric Multi-Instrument Comparison Study.Pharmacoeconomics. 2024 Jun;42(Suppl 1):39-55. doi: 10.1007/s40273-023-01330-2. Epub 2023 Nov 13. Pharmacoeconomics. 2024. PMID: 37955799 Free PMC article.
-
A review of the psychometric properties of generic utility measures in multiple sclerosis.Pharmacoeconomics. 2014 Aug;32(8):759-73. doi: 10.1007/s40273-014-0167-5. Pharmacoeconomics. 2014. PMID: 24846760 Review.
-
A Review of the Psychometric Performance of Selected Child and Adolescent Preference-Based Measures Used to Produce Utilities for Child and Adolescent Health.Value Health. 2021 Mar;24(3):443-460. doi: 10.1016/j.jval.2020.09.012. Epub 2020 Nov 7. Value Health. 2021. PMID: 33641779 Review.
Cited by
-
Comparing the Psychometric Performance of Generic Paediatric Health-Related Quality of Life Instruments in Children and Adolescents with ADHD, Anxiety and/or Depression.Pharmacoeconomics. 2024 Jun;42(Suppl 1):57-77. doi: 10.1007/s40273-024-01354-2. Epub 2024 Feb 8. Pharmacoeconomics. 2024. PMID: 38329689 Free PMC article.
-
Measuring and Valuing Health Using EuroQol Instruments: New Developments 2025 and Beyond.Appl Health Econ Health Policy. 2025 Jul 24. doi: 10.1007/s40258-025-00989-2. Online ahead of print. Appl Health Econ Health Policy. 2025. PMID: 40705271 Review.
-
Validity and responsiveness of EQ-5D-Y in children with haematological malignancies and their caregivers.Eur J Health Econ. 2024 Nov;25(8):1361-1370. doi: 10.1007/s10198-024-01669-z. Epub 2024 Feb 14. Eur J Health Econ. 2024. PMID: 38356007
-
Systematic Review of the Psychometric Performance of Generic Childhood Multi-attribute Utility Instruments.Appl Health Econ Health Policy. 2023 Jul;21(4):559-584. doi: 10.1007/s40258-023-00806-8. Epub 2023 May 3. Appl Health Econ Health Policy. 2023. PMID: 37133712 Free PMC article.
-
Psychometric validation of the Chinese versions of EQ-5D-Y-3L and the experimental EQ-TIPS in children and adolescents with COVID-19.Eur J Health Econ. 2025 Apr;26(3):337-351. doi: 10.1007/s10198-024-01710-1. Epub 2024 Jul 27. Eur J Health Econ. 2025. PMID: 39066840 Free PMC article.
References
-
- Brazier JE, Dixon S, Ratcliffe J. The role of patient preferences in cost-effectiveness analysis. Pharmacoeconomics. 2009;27(9):705–12.
-
- Allen JD, et al. The value of addressing patient preferences. Value Health. 2017;20(2):283–5.
-
- Boivin A, et al. Patient and public involvement in clinical guidelines: international experiences and future perspectives. Qual Saf Health Care. 2010;19(5):e22–e22.
-
- Prinsen CA, et al. COSMIN guideline for systematic reviews of patient-reported outcome measures. Qual Life Res. 2018;27(5):1147–57.
-
- Feng Y, et al. An exploration of differences between Japan and two European countries in the self-reporting and valuation of pain and discomfort on the EQ-5D. Qual Life Res. 2017;26(8):2067–78.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources